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ABSTRACT
Methods: A 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was utilized to screen the cytotoxic activity.
Results: The results revealed that the formulation does not induce much mortality in normal liver and kidney cell lines, and LC50 value of liver cell lines 
was found 1716.355 µg/ml and kidney cell lines 2464.910 µg/ml. The in vitro anticancer activity was performed on liver, colon, and prostate cancer 
cell lines, and IC50 values are found 2.077, 3.850, and 11.989 µg/ml, respectively, which show excellent anticancer activity.
Conclusion: Based on the results obtained, the hepatoprotective polyherbal formulation is safe for normal cells and cytotoxic for cancer cells. Further, 
identification and quantification of phytoconstituents responsible for the activity are in progress.
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INTRODUCTION
In recent years, most of the world population is witnessing medicine going 
back to nature - a shift in global trend from synthetic to natural medicine. 
In the ancient days also, medicinal herbs are used to treat several diseases. 
Even today for health maintenance, the Indian traditional medical systems 
such as Ayurveda, Siddha, Unani, Homeopathy, Yoga, and Naturopathy 
are practiced and accepted by worldwide population. Nowadays, more 
research is going on phytomedicine, and several botanical preparations 
are evaluated for its potential therapeutic efficacy. Among those botanical 
drugs, anticancer and hepatoprotective agents are standing in front [1]. 
Oncology-related cases are increasing day by day due to environmental 
pollution, food, and lifestyle modifications. Currently, cancer is treated 
by chemotherapy, surgery, and radiation therapy. Most of the synthetic 
anticancer drugs are used for the treatment which show severe adverse 
effects [2]. Recently, most of the oncology-related researchers are trying 
to identify botanical preparations which show maximum anticancer 
effect with a minimum side effect. Semisynthetic or isolated active 
components from botanical origin such as Catharanthus roseus, Taxus 
brevifolia, Podophyllum emodi, and Camptotheca acuminata have been 
used in the treatment cancer [3]. The selected polyherbal formulation 
is made up of hydroalcoholic extract of different indigenous medicinal 
plants with specific ratio. The main objective of this study is to investigate 
cytotoxic potential and anticancer activity of a polyherbal ayurvedic 
formulation in cell line model.
METHODS
Chemicals and cell lines
All the required chemicals and reagents are analytical grade and 
procured from Loba Chemie Laboratory Reagents and HiMedia. The 
cell lines were obtained from the National Center for Cell Sciences, 
Pune, India, and grown on Dulbecco’s Modified Essential Medium 
supplemented with 10% (v/v) fetal calf serum, penicillin (100 U/ml), 
and streptomycin (100 µg/ml).
Preparation of hydroalcoholic extract
The formulation is made up of five herbal ingredients in different ratios. 
Phytochemical extraction was done by cold maceration method using 
double-distilled water and ethanol in the ratio of 7:3 and kept for 48 h 
by occasional shaking. The residue was filtered through double-lined 
muslin cloth and evaporated to dryness under reduced pressure using 
vacuum evaporator. The resulting greenish-black material (LVR05) was 
kept in an airtight container at 4°C.
Determination of in vitro cytotoxicity and anticancer activity
In vitro cytotoxicity and anticancer activity were assessed by 
3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay [4-9]. Two different experiments were carried out using the same 
procedure for assessing cytotoxicity and anticancer efficacy of test 
drug, and the percentage of cell viability and mortality was calculated 
using standard formula.
RESULTS AND DISCUSSION
In vitro cytotoxicity studies
The in vitro cytotoxicity studies give us a good idea about advantages 
and disadvantages of the model for screening and mechanistic analysis 
of potentially toxic compounds. A wide array of morphologic and 
biochemical markers are available for obtaining information at the 
cellular and molecular levels to detect chemical-induced disruption [10]. 
Among the methods, in vitro cell line models are quite easy to perform 
in laboratory conditions. Different concentrations of LVR05 were tested 
against normal liver and kidney cell lines, and the toxicity was assessed 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Research Article
Objective: The use of natural products as anticancer agents has a long history that began with folklore medicine and through the years has been 
incorporated  into traditional and allopathic medicine. Several drugs currently used are derived from medicinal plants.
The main objective of this study is to investigate the cytotoxic potential of hepatoprotective polyherbal formulation in normal and cancer cell lines.
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by MTT assay (Tables 1 and 2) and calculated LC50 using lethal dose 
probability line software (Figs. 1 to 10).
In vitro cytotoxicity data are useful for assessing the toxicity of 
particular material and also indicate the need for specific kinds 
Fig. 1: Cytotoxic effect of LVR05 on normal liver cell lines percentage of viability and mortality
Table 1: Cytotoxic effect of different concentrations of LVR05 on normal cell lines (Chang liver cells)
S. No Concentration (µg/ml) Absorbance (O.D) Cell mortality (%) Cell viability (%)
1 500 0.89 29.92 70.07
2 250 0.95 25.19 74.80
3 125 1.02 19.68 80.31
4 62.5 1.10 13.38 86.61
5 31.25 1.18 7.08 92.91
6 15.63 1.21 4.72 95.27
7 7.81 1.25 1.57 98.42
9 Cell control 1.27 0 100
µg: Micrograms, O.D: Optical density, LVR05: Hepatoprotective polyherbal formulation
Table 2: Cytotoxic effect of different concentrations of LVR05 on normal kidney cell lines (vero cells)
S. No Concentration (µg/ml) Absorbance (O.D) Cell mortality (%) Cell viability (%)
1 500 0.80 31.04 68.96
2 250 0.95 18.11 81.89
3 125 1.02 12.07 87.93
4 62.5 1.05 9.49 90.51
5 31.25 1.10 5.18 94.82
6 15.63 1.12 4.45 95.55
7 7.81 1.14 1.73 98.27
9 Cell control 1.16 0 100
µg: Micrograms, O.D: Optical density, LVR05: Hepatoprotective polyherbal formulation
Fig. 2: LC50 value of LVR05 on normal liver cell lines was calculated by lethal dose probability line software
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Fig. 4: LC50 calculation by lethal dose probability line software
Fig. 3: Cytotoxic effect of LVR05 on normal kidney (vero) cell lines percentage of viability and mortality
Fig. 5: Anticancer activity of different concentrations of LVR05 on liver cancer (HepG2) cell lines
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Fig. 7: Anticancer activity of different concentrations of LVR05 on colon cancer cell lines
Fig. 8: LC50 calculation by lethal dose probability line software
Fig. 6: LC50 calculation by lethal dose probability line software
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Fig. 10: LC50 calculation by lethal dose probability line software
Fig. 9: Anticancer activity of different concentrations of LVR05 on prostate cancer cell lines
of additional toxicity tests that would be required . Any drug 
administered in to the system, undergoes metabolism in the liver. 
The liver is the primary organ which is exposed more to the drugs 
and toxicants. After the metabolism completed, it should eliminate 
through the kidney. During the elimination process, there are 
chances of causing damage to the kidney cells. Based on the results 
obtained from the cytotoxic activity, the polyherbal formulation does 
not induce any abnormality in normal liver and kidney cells which 
indicates its safety.
In vitro anticancer studies
Cellular screening in cancer research mainly consists of human tumor 
cell lines. It is the most suitable system in terms of management and 
reproducibility [11]. Currently, different concentrations of LVR05 were 
tested against liver, colon, and prostate cell lines and results found very 
effective.
Liver cancer or hepatocellular carcinoma has a low survival rate, 
and major risk factors include excessive alcohol intake, hepatitis, 
smoking, and high-grade fatty liver. Symptoms generally appear 
when cancer reaches an advanced stage. Treatment options for liver 
cancer include surgery and liver transplantation [12]. There is a 
huge demand for safe and promising therapeutic agents which can 
reduce the incidence of liver cancer. Based on results obtained, the 
polyherbal formulation shows potent anticancer activity in dose-
dependent manner. Even at low concentration (50 µg/ml), there was 
no cancerous cell viable which indicates the anticancer efficacy of the 
formulation.
Colon cancer is cancer of the large intestine (Colon), which is the 
final part of the digestive tract. Colon cancer starts with small, non-
cancerous clumps of cells called adenomatous polyps. These polyps can 
become cancerous when continuous inflammation occurs in the colon. 
Till date, it is not clear what causes colon cancer and the cases of colon 
cancer are increasing [13,14]. The formulation is inhibiting the growth 
of colon cancer cells in dose dependent manner. At the concentration 
of 25µg/ml, cancer cell viability was 3.1% and mortality 96.9%. At the 
concentration of 50µg/ml there was no growth at all.
The incidence of prostate cancer is one of the most widespread cancer 
diagnoses in every part of the world. The pathogenesis of prostate 
cancer has remained a perplex issue [15]. In this study, the LVR05 
inhibits prostate cancer cell growth 91.8% at the concentration of 
50 µg/ml.
325
Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 320-325
 Kuncha et al. 
CONCLUSION
Based on the above results, it is concluded that the polyherbal 
formulation has not induced much toxicity in normal liver and kidney 
cell lines which indicate safe when taken internally. The hydroalcoholic 
extract possesses excellent anticancer activity on liver, colon, and 
prostate cancer cell lines. Further, identification and quantification of 
phytoconstituents responsible for the activity are in progress.
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